THE +3953 (C->T) POLYMORPHISM OF INTERLEUKIN-1β
GENE IN MYOCARDIAL INFARCTION IN TATARS AND
RUSSIANS FROM BASHKORTOSTAN Tulyakova G1,*, Nasibullin T1, Zakirova A2, Khusnutdinova E1, Mustafina O1 *Corresponding Author: Dr. Gulnara Tulyakova, Institute of Biochemistry and Genetics, Ufa Research Center, Russian Academy of Sciences, October Avenue 69, 450054 Ufa, Bashkortostan, Russia; Tel.: +7-3472-361176; Fax: +7-3472-356100; E-mail: gulnarat@mail.ru page: 65
|
Abstract
Interleukin-1b (IL-1b) plays an important role in the pathogenesis of atherosclerosis and myocardial infarction (MI). The aim of this study was to test whether the +3953 (C→T) polymorphism of IL-1β gene in exon 5 is associated with MI in Russians and Tatars of Bashkortostan. We examined 306 male patients with MI and 245 healthy controls. Genotype frequencies for IL-1β exon 5 polymorphisms in Russian controls: 71 E1 homozygotes (61.2%), 40 E1/E2 heterozygotes (34.5%), five E2 homozygotes (4.3%), and in Tatar controls 73 (56.6%), 46 (35.7%) and 10 (7.8%), respectively, and were similar to those reported for North American Caucasian healthy controls. In the MI patients, the genotype frequencies in Russians were 110 E1/E1 (53.9%), 67 E1/E2 (35.1%), 21 E2/E2 (11.0%), and in Tatars 73 (56.6%), 46 (35.7%) and 10 (7.8%), respectively. No significant differences in allele or genotype frequencies were found between the patient and the control groups. In the subgroup of Russian patients with a body mass index (BMI) of ≥25 and left ventricular hypertrophy (LVH), frequencies of the E2 allele and E2/E2 genotype were significantly higher than in the control group. This study shows that the +3953 (C→T) IL-1β gene polymorphism may be a genetic risk factor for the development of MI in Russian patients with a BMI of ≥25 and with LVH.
Key words: Atherosclerosis; Gene; Interleukin-1β (IL-1β); Myocardial infarction (MI); Polymorphism.
|
|
|
|
|
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|